Chad Robins

Chad Robins

Chief Executive Officer at ADAPTIVE BIOTECHNOLOGIES CORPORATION

Net worth: 49 M $ as of 31/07/2026

51 year
Commercial Services
Health Technology
Consumer Services

Profile

Mr. Chad Robins is an Independent Director at CM Life Sciences III, Inc. and a Chairman & Chief Executive Officer at Adaptive Biotechnologies Corp. He is on the Board of Directors at CM Life Sciences III, Inc., Aortica Corp., AdvaMedDx, AltPep Corp. and HeadLight Technologies, Inc. He received his undergraduate degree from Cornell University and an MBA from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
18/08/2026 21,80,518 ( 1.36% ) 49 M $ 31/07/2026

Chad Robins active positions

CompaniesPositionStart
ADAPTIVE BIOTECHNOLOGIES CORPORATION Chief Executive Officer 08/09/2009
Director/Board Member 01/01/2015
Founder 01/01/2014
Director/Board Member -
Director/Board Member -
Chairman 01/01/2024
Director/Board Member 01/03/2020
Director/Board Member -

Former positions of Chad Robins

CompaniesPositionEnd
CEREVEL THERAPEUTICS HOLDINGS, INC. Director/Board Member -
░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Chad Robins's experience

Training of Chad Robins

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Technology Services

Commercial Services

Finance

Finance